Completed PHASE3 INTERVENTIONAL 2-arm NCT03669484

Comparative Clinical Study of Efficacy and Safety of Remimazolam and Propofol in Patients Undergoing Elective Surgery Under General Anaesthesia

International Multicenter Single Blind Randomized Clinical Study to Compare Efficacy and Safety of Remimazolam and Propofol in Patients Undergoing Elective Surgical Procedures Under General Anesthesia

Sponsor: R-Pharm

Conditions General Anaesthesia

Interventions Fentanyl Propofol Remimazolam Rocuronium bromide

Updated 5 times since 2018 Last updated: Sep 11, 2018 Started: Aug 22, 2017 Primary completion: May 15, 2018 Completion: May 24, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on General Anaesthesia, this trial is completed. The trial is conducted by R-Pharm and has accumulated 5 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Oct 2018 — Jan 2021 [monthly]

Completed PHASE3

First recorded

Aug 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

R-Pharm
Synergy Research Inc.

Data source: R-Pharm

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Moscow, Russia